WT-1 was initially discovered as a tumor suppressor in Wilms’ tumor, and is expressed in most serous adenocarcinomas of the ovary and peritoneum and mesotheliomas, as well as in Wilms’ tumors. This evidence concerns the gene WT1 and Nephroblastoma.